BioPharma Credit PLC (LON:BPCP)

London flag London · Delayed Price · Currency is GBP · Price in GBX
71.10
-0.60 (-0.84%)
At close: Mar 27, 2026
Market Cap797.03M +0.7%
Revenue (ttm)117.21M +5.1%
Net Income96.51M +6.3%
EPS0.08 +14.0%
Shares Outn/a
PE Ratio8.26
Forward PEn/a
Dividend0.06 (8.52%)
Ex-Dividend DateFeb 19, 2026
Volume147,216
Average Volume181,282
Open70.42
Previous Close71.70
Day's Range70.42 - 72.01
52-Week Range60.40 - 72.01
Betan/a
RSI55.10
Earnings DateMar 24, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom. [Read more]

Sector Financials
Founded 2016
Country United Kingdom
Stock Exchange London Stock Exchange
Ticker Symbol BPCP

Financial Performance

In 2025, BioPharma Credit's revenue was $157.75 million, an increase of 5.14% compared to the previous year's $150.03 million. Earnings were $129.89 million, an increase of 6.31%.

Financial numbers in USD Financial Statements